Improved cytotoxicity of paclitaxel loaded in nanosized lipid carriers by intracellular delivery
Improved cytotoxicity of paclitaxel loaded in nanosized lipid carriers by intracellular delivery
复制标题
通过细胞内递送改善纳米脂质载体中负载的紫杉醇的细胞毒性
DOI:
10.1007/s11051-014-2852-x
复制
发表时间:
2015-01-11
影响因子:
2.5
通讯作者:
Hu, Fuqiang
中科院分区:
文献类型:
--
作者:
Miao, Jing;Du, Yongzhong;Hu, Fuqiang
Nanosized lipid carriers (NLC) can improve the limited drug-loading (DL) capacity and drug expulsion during storage, and adjust the drug release profile of solid lipid nanoparticles (SLN). In this study, Paclitaxel (PTX)-loaded NLC were prepared by solvent diffusion method using monostearin as solid lipid and oleic acid (OA) as liquid lipid matrix. The blank NLC with different OA content (the size range was from 89.5 ± 7.4 to 160.2 ± 34.6 nm) showed smaller size than the blank SLN (the size was 272.7 ± 43.6 nm), while the PTX-loaded NLC (the size range was from 481.3 ± 29.8 to 561.7 ± 38.3 nm) showed little bigger size, higher DL capacity, and faster drug in vitro release rate comparing with SLN (the size was 437.3 ± 68.2 nm). The 50 % cellular growth inhibitions (IC50) of PTX-loaded NLC with 0, 5, 10, and 20 wt % OA were 0.92 ± 0.06, 0.69 ± 0.04, 0.25 ± 0.02, and 0.12 ± 0.02 µg mL−1, respectively, while the IC50of TaxolTMwas 1.72 ± 0.09 µg mL−1. For analyzing cellular drug effect, cellular uptakes of fluorescent NLC and intracellular drug concentration were investigated. As the incorporation of OA into solid lipid matrix could accelerate both the cellular uptake and the PTX delivery, loaded by NLC, the cytotoxicity of PTX could be enhanced, and further enhanced by increasing OA content in NLC.